awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38435358-2DA5A2ED-2963-4C30-A304-B8C93D013293
Q38435358-2DA5A2ED-2963-4C30-A304-B8C93D013293
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38435358-2DA5A2ED-2963-4C30-A304-B8C93D013293
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.
P2860
Q38435358-2DA5A2ED-2963-4C30-A304-B8C93D013293
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38435358-2DA5A2ED-2963-4C30-A304-B8C93D013293
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f7e26b00ecf41556c37b42054851e95dc9bf1638
P2860
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.